Valproate - Pregnancy Prevention Information

Following 5 years of work by INFACT, In April 2018 a new Mandatory Action for the use of Valproate in women of child bearing age was put in place  by the Medicines & Healthcare Products Regulatory Agency (MHRA) called the Pregnancy Prevention Plan (PPP).  This was to ensure the women were given the warnings of the risk of Valproate when used in pregnancy and those who could use other medications were able to do so.  Any women who had tried all other possibilities continued to use Valproate with the use of the PPP.  It is important to ensure all women are made aware of this and for INFACT to report any way in which this new system may be failing.
 
INFACT and its parental support group FACSA have been inundated with calls recently from women prescribed Valproate explaining the confusion and laxck of understanding this has caused.
 
In order for INFACT and FACSA to understand whether the PPP is to be sucessful it is important we can produce percentages to the MHRA on our next meeting with them.

Question Title

* 1. Have you been prescribed any form of  Sodium Valproate over the past 2 years and continue to do so.

Question Title

* 2. What is your dose of Valproate per day

Question Title

* 3. On collection of your prescription from the Pharmacy, do you receive your tablets/medicine in a Purple Box

Question Title

* 4. Or, on collection of your prescription from the pharmacy do you receive your medication in a White Chemist Box

Question Title

* 5. If you receive the White Chemist Box, does it contain a Patient Information Leaflet

Question Title

* 6. Have you received a small credit card size information from your pharmacist

Question Title

* 7. Over the past 6 months, has your GP discussed with you the New Warnings on Valproate in Pregnancy

Question Title

* 8. If you have discussed with your GP or Neurologist, was it done in a way your fully understood

Question Title

* 9. If your answer to number 8 is No, please explain why you did not understand fully.

Question Title

* 10. Have you been asked to sign an Acknowledgment of Risk From by your GP/Neurologist to say you have been told of the risks of Valproate in pregnancy

Question Title

* 11. Has your GP, Neurologist or Psychiatrist suggested a change in medication, other than Valproate

Question Title

* 12. Which medication for Epilepsy has he/she suggested your try

Question Title

* 13. If you are prescribed Valproate for any other condition such as Bipolar or Migraine please note which medication, other than Valproate your Dr has suggested for you.

Question Title

* 14. Thank you for taking the INFACT Survey on Valproate - Pregnancy Prevention Information, if you have children already affected by Valproate in pregnancy who are born in the UK and wish your names to be added to the INFACT Database please add your details below.

Question Title

* 15. If you have completed the contact form these 2 questions are important:

A)  Does your child/children have a diagnosis of Fetal Valproate Syndrome
B)  What was your dose of Valproate during pregnancy

Question Title

* 16. If you have any questions or need further information on Fetal Valproate Syndrome or Valproate in Pregnancy please visit our website at
  https://infactuk.com/ 

T